HB 169 bars Wyoming state agencies and political subdivisions from using public funds to pay membership fees, dues, or related expenses for four specific organizations: the Environmental Council of the States, Council of Chief State School Officers, National Association of Medicaid Directors, and Association of State and Territorial Health Officials. The law prohibits payments for membership benefits (excluding goods/services), travel, conference fees, or event costs tied to these groups. It applies to all state funds appropriated by the legislature or received by agencies, effective July 1, 2026. This policy change directly affects state agency budgets and spending decisions related to these designated organizations.
HB 166 reclassifies marijuana as a Schedule III controlled substance under Wyoming law, directly affecting medical users and providers who previously relied on state-recognized prescriptions. The bill amends definitions to clarify that "edible products" containing THC (like gummies or baked goods) and "analog" substances with similar effects to marijuana are included in this classification. Crucially, it prohibits practitioners from prescribing or dispensing marijuana, tetrahydrocannabinol (THC), or synthetic equivalents - even for medical use - unless the substance has U.S. FDA approval (like dronabinol). This would effectively ban medical marijuana in Wyoming while maintaining existing penalties for possession under Schedule III rules. The bill is pending, having been assigned a number in 2026 but not yet considered for introduction.
SF 106 amends Wyoming's welfare and Medicaid eligibility rules to strengthen verification processes. It requires monthly checks of residency and death records, bans self-attestation for income, citizenship, and household composition without verification, and limits retroactive Medicaid coverage to two months. The bill directly affects welfare applicants and recipients, including both citizens and noncitizens, by tightening eligibility requirements. Key provisions include shorter recertification periods for unstable households (up to 4 months) and mandatory reporting to the legislature on program impacts. These changes aim to prevent program misuse while aligning with federal requirements.
Wyoming's HB 126, the "Human heartbeat act," prohibits most abortion procedures after a detectable fetal heartbeat is identified (typically around 6 weeks gestation), directly affecting pregnant individuals seeking abortions and healthcare providers performing them. The bill requires healthcare providers to confirm a detectable heartbeat via standard medical equipment before proceeding with an abortion, except in cases of medical emergencies that threaten the patient's life or major bodily function. Violations are classified as felonies punishable by up to five years in prison or $10,000 fines, and healthcare professionals face mandatory license revocation for noncompliance. The law creates new definitions, exceptions for medical emergencies, and penalties for violations, effective upon enactment.
This bill amends Wyoming's Pharmacy Act to raise the minimum age for pharmacists to administer vaccines from 3 to 7 years old, directly affecting children under 7 who previously could receive immunizations from pharmacists. It also adds protections preventing employers from discriminating against pharmacists who decline to provide collaborative pharmacy care or administer vaccines to children under 13. The bill requires the Board of Pharmacy to create rules for collaborative care and vaccine administration, with most provisions taking effect July 1, 2026. These changes clarify pharmacist authority, patient eligibility, and workplace protections under the state's pharmacy regulations.
HB 13 would allow human-use ivermectin to be sold as an over-the-counter medication in Wyoming without a prescription or consultation with a healthcare provider. The bill directly affects pharmacies and consumers by removing current prescription requirements for this medication. Key provisions define "over-the-counter medication" and specify that ivermectin cannot be classified as a dangerous substance or a controlled substance under existing laws. The law would take effect on July 1, 2026.
This bill updates Wyoming's Medicaid eligibility rules by codifying current state criteria into law. It directly affects individuals applying for Wyoming Medicaid, requiring applicants to be U.S. citizens or lawfully present, Wyoming residents, and meet one of several specific criteria (such as disability, supplemental security income eligibility, hospice care, or tuberculosis infection). The bill prevents Medicaid expansion beyond current eligibility levels as of July 1, 2026, without legislative approval. The Department of Health must finalize implementing rules by October 1, 2026, and the new rules apply to applications submitted or renewed on or after July 1, 2027.
